Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Layden

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Trends in Endocrinology and Metabolism: TEM|November 16, 2021
Hexokinase domain-containing protein-1 in metabolic diseases and beyondJoseph L Zapater, Kristen R Lednovich, Md Wasim Khan, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 20, 2020
Free fatty acid receptor 3 differentially contributes to β-cell compensation under high-fat diet and streptozotocin stressMedha Priyadarshini, Connor Cole, Gautham Oroskar, et al.
Pituitary|January 19, 2019
Oxytocin alterations and neurocognitive domains in patients with hypopituitarismYuval Eisenberg, Shatha Murad, Alessandra Casagrande, et al.
Preventive Medicine Reports|May 21, 2025
Preferences for receiving diabetes prevention support and factors influencing healthy eating and physical activity and among patients with prediabetes in Chicago, IllinoisAngela Kong, Mary Smart, Yuka Asada, et al.
Plos One|December 14, 2016
FFA2 Contribution to Gestational Glucose Tolerance Is Not Disrupted by AntibioticsMiles Fuller, Xiaoran Li, Robert Fisch, et al.
Frontiers in Endocrinology|January 23, 2023
The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?Raza Ali Naqvi, Afsar Raza Naqvi, Amar Singh, et al.
Diabetes|January 24, 2015
New insights into gestational glucose metabolism: lessons learned from 21st century approachesAnthony R Angueira, Anton E Ludvik, Timothy E Reddy, et al.
Diabetes, Obesity & Metabolism|July 5, 2018
Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort studySruthi Adimadhyam, Todd A Lee, Gregory S Calip, et al.
British Journal of Clinical Pharmacology|October 9, 2018
Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysisSruthi Adimadhyam, Glen T Schumock, Gregory S Calip, et al.
Plos One|March 30, 2018
Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic diseaseElena Barengolts, Stefan J Green, Yuval Eisenberg, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Trends in Endocrinology and Metabolism: TEM|November 16, 2021
Hexokinase domain-containing protein-1 in metabolic diseases and beyondJoseph L Zapater, Kristen R Lednovich, Md Wasim Khan, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 20, 2020
Free fatty acid receptor 3 differentially contributes to β-cell compensation under high-fat diet and streptozotocin stressMedha Priyadarshini, Connor Cole, Gautham Oroskar, et al.
Pituitary|January 19, 2019
Oxytocin alterations and neurocognitive domains in patients with hypopituitarismYuval Eisenberg, Shatha Murad, Alessandra Casagrande, et al.
Preventive Medicine Reports|May 21, 2025
Preferences for receiving diabetes prevention support and factors influencing healthy eating and physical activity and among patients with prediabetes in Chicago, IllinoisAngela Kong, Mary Smart, Yuka Asada, et al.
Plos One|December 14, 2016
FFA2 Contribution to Gestational Glucose Tolerance Is Not Disrupted by AntibioticsMiles Fuller, Xiaoran Li, Robert Fisch, et al.
Frontiers in Endocrinology|January 23, 2023
The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?Raza Ali Naqvi, Afsar Raza Naqvi, Amar Singh, et al.
Diabetes|January 24, 2015
New insights into gestational glucose metabolism: lessons learned from 21st century approachesAnthony R Angueira, Anton E Ludvik, Timothy E Reddy, et al.
Diabetes, Obesity & Metabolism|July 5, 2018
Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort studySruthi Adimadhyam, Todd A Lee, Gregory S Calip, et al.
British Journal of Clinical Pharmacology|October 9, 2018
Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysisSruthi Adimadhyam, Glen T Schumock, Gregory S Calip, et al.
Plos One|March 30, 2018
Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic diseaseElena Barengolts, Stefan J Green, Yuval Eisenberg, et al.
Pageof 15